Curis, Inc.Curis, Inc.Curis, Inc.

Curis, Inc.

No trades
See on Supercharts
Market capitalization
‪94.01 M‬USD
−9.03USD
‪−47.41 M‬USD
‪10.02 M‬USD
‪5.88 M‬
Beta (1Y)
2.60

About Curis, Inc.

CEO
James E. Dentzer
Website
Headquarters
Lexington
Employees (FY)
49
Founded
2000
ISIN
US2312693094
FIGI
BBG000C1GTC9
Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CRIS is 15.22 USD — it has decreased by 4.58% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Curis, Inc. stocks are traded under the ticker CRIS.
Curis, Inc. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
CRIS stock is 12.78% volatile and has beta coefficient of 2.60. Check out the list of the most volatile stocks — is Curis, Inc. there?
One year price forecast for Curis, Inc. has a max estimate of 26.00 USD and a min estimate of 15.00 USD.
CRIS earnings for the last quarter are −2.13 USD whereas the estimation was −2.33 USD which accounts for 8.43% surprise. Estimated earnings for the next quarter are −2.12 USD. See more details about Curis, Inc. earnings.
Curis, Inc. revenue for the last quarter amounts to ‪2.83 M‬ USD despite the estimated figure of ‪2.54 M‬ USD. In the next quarter revenue is expected to reach ‪3.02 M‬ USD.
Yes, you can track Curis, Inc. financials in yearly and quarterly reports right on TradingView.
CRIS stock has fallen by 1.30% compared to the previous week, the month change is a 46.63% rise, over the last year Curis, Inc. has showed a 19.10% decrease.
CRIS net income for the last quarter is ‪−11.71 M‬ USD, while the quarter before that showed ‪−12.18 M‬ USD of net income which accounts for 3.85% change. Track more Curis, Inc. financial stats to get the full picture.
Today Curis, Inc. has the market capitalization of ‪94.01 M‬, it has increased by 33.93% over the last week.
No, CRIS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CRIS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Curis, Inc. stock right from TradingView charts — choose your broker and connect to your account.
CRIS reached its all-time high on Aug 1, 2000 with the price of 2725.00 USD, and its all-time low was 3.80 USD and was reached on Oct 24, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 49.00 employees. See our rating of the largest employees — is Curis, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Curis, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Curis, Inc. stock shows the neutral signal. See more of Curis, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Curis, Inc. future price: according to them, CRIS price has a max estimate of 26.00 USD and a min estimate of 15.00 USD. Read a more detailed Curis, Inc. forecast: see what analysts think of Curis, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Curis, Inc. EBITDA is ‪−47.42 M‬ USD, and current EBITDA margin is −479.67%. See more stats in Curis, Inc. financial statements.